SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for GSK (GSK) — Oct 15, 2012

GSK plc
Date: Oct. 15, 2012 · CIK: 0001131399 · Accession: 0000000000-12-056849

AI Filing Summary & Sentiment

File numbers found in text: 001-15170

Date
December 31, 2011
Author
/s/ Gus Rodriguez
Form
UPLOAD
Company
GSK plc

Letter

Octo ber 1 5, 2012 Via E -mail Mr. Simon Dingemans Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford, TW8 9GS England

Re: GlaxoSmithKline plc Form 20 -F for the Fiscal Year Ended December 31, 2011 Filed March 13, 2012 File No. 001-15170

Dear Mr. Dingemans :

We have comple ted our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the Un ited States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Gus Rodriguez

Show Raw Text
Octo ber 1 5, 2012

Via E -mail
Mr. Simon Dingemans
Chief Financial  Officer
GlaxoSmithKline plc
980 Great West Road
Brentford, TW8 9GS
England

Re:  GlaxoSmithKline plc
 Form 20 -F for the Fiscal Year Ended December  31, 2011
Filed March 13, 2012
 File No. 001-15170

Dear Mr. Dingemans :

We have comple ted our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the Un ited States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

        /s/ Gus Rodriguez

Gus Rodriguez
Accounting Branch Chief